HomeStock ScreenerAstal Laboratories

Astal Laboratories Share Price | Astal Laboratories Stock Screener

ASTALLTD Trading & Distributors
Share Price BSE
₹80.70
▼ -1.08 (-1.32%)
2026-06-22 00:00:00
As of June 22, 2026, the Astal Laboratories share price (BSE: ASTALLTD) is ₹80.70, down 1.32% from the previous close, with shares trading between ₹80.00 and ₹84.00, and a 52-week range of ₹61.52–₹100.62. Check Astal Laboratories yearly highs lows for the annual price range and momentum. Use the Astal Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Astal Laboratories Market Cap ₹357.41 Cr.
ASTALLTD P/E Ratio (TTM) 24.99
Astal Laboratories P/B Ratio 1.08
EPS (TTM) ₹4.76
Dividend Yield -
Debt to Equity 0.23
ASTALLTD 52 Week High ₹100.62
Astal Laboratories 52 Week Low ₹61.52
Operating Margin 8.00%
Profit Margin 5.97%
ASTALLTD Revenue (TTM) ₹134.00
EBITDA ₹10.00
Net Income ₹8.00
Total Assets ₹400.00
Total Equity ₹327.00

Astal Laboratories Share Price Chart

Screen Astal Laboratories share price with an interactive chart. Analyse ASTALLTD price trends and volatility across different timeframes.

Astal Laboratories Company Profile - Fundamental Screener

Screen Astal Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTALLTD shares.
Sector Commercial Services
Industry Trading & Distributors
Sub-Sector Trading & Distributors
Segment E
ISIN INE307N01014

Astal Laboratories Balance Sheet Screener

Screen ASTALLTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 400 63 37 10 5 5 5 5 5 5
Current Assets 103 46 27 6 0 0 5 5 5 5
Fixed Assets 12 11 1 0 0 0 0 0 0 0
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 327 36 23 5 5 5 5 5 5 5
Share Capital 42 10 10 4 4 4 4 4 4 4
Reserves & Surplus 285 22 14 1 1 1 1 1 1 1

Astal Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Astal Laboratories income statement and profit fundamentals. Analyze ASTALLTD quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Astal Laboratories share price evaluation.
Item 2026-Mar 2025-Mar 2025-Dec
Revenue 134 24 52
Expenses 124 19 49
EBITDA 10 4 4
Operating Profit % 8.00% 18.00% 7.00%
Depreciation 1 0 0
Interest 1 0 0
Profit Before Tax 8 4 3
Tax 1 1 1
Net Profit 8 3 2
EPS 0.29 2.80 2.19

Astal Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen ASTALLTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities -13 -6 -1 0 0 0 0 0 0 0
Investing Activities -8 -6 2 0 0 0 0 0 0 0
Financing Activities 3 18 0 0 0 0 0 0 0 0
Net Cash Flow -17 6 0 0 0 0 0 0 0 0

Astal Laboratories Shareholding Pattern Screener

See Astal Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Astal Laboratories promoter holding and ownership changes for ASTALLTD on TickJournal.
Item 2026-Mar 2026-May 2025-Mar 2025-Jun 2025-Aug 2025-Sept 2025-Dec 2024-Feb
Promoter Holding 4.70% 4.53% 19.93% 19.93% 18.19% 18.19% 18.19% 19.93%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 80.10% 80.72% 73.80% 73.42% 73.61% 73.50% 73.06% 73.53%
Other Holding 15.20% 14.74% 6.26% 6.65% 8.20% 8.31% 8.75% 6.53%
Shareholder Count 3,065 3,313 2,302 2,721 2,950 2,899 2,926 1,252

Astal Laboratories Share Dividend Screener - Share Yield Analysis

Check Astal Laboratories dividend history with payout and yield data. View Astal Laboratories dividend details including ex-dates and amounts for ASTALLTD stock.
No dividends declared by Astal Laboratories.

Astal Laboratories Stock Index Membership

See which indices include Astal Laboratories stock. Check ASTALLTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Astal Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Astal Laboratories Market Events Screener - Corporate Actions

Get Astal Laboratories corporate actions including splits, bonuses, and buybacks. Check Astal Laboratories stock events that may affect ASTALLTD share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -13.90%
2026-05-30 2026-05-30 Quarterly Result Announcement NA -0.50%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -0.91%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -2.18%
2025-11-06 2025-11-06 Extraordinary General Meeting NA -1.89%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 6.22%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 8.40%
2025-01-27 2025-01-27 Quarterly Result Announcement NA 14.76%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -3.14%
2024-08-05 2024-08-05 Annual General Meeting NA 36.71%
2023-12-19 2023-12-19 Change Of Name NA 0.00%

Astal Laboratories Competitors Screener - Peer Comparison

Screen ASTALLTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Redington 21,949 16.55 119,162 19.69% 1,158 75.59
MMTC 11,183 29.07 1 -99.46% 550 65.44
MSTC 4,877 22.14 370 -4.60% 221 80.12
Elitecon International 4,557 13.79 551 55040.00% 70 35.80
Ravindra Energy 3,389 35.45 543 107.17% 84 73.96
BN Agrochem 2,757 80.43 873 137.82% 17 45.93
Vintage Coffee & Beverages 2,198 30.51 553 76.98% 72 56.69
TCC Concept 1,651 25.33 179 100.21% 31 37.23
Creative Newtech 1,131 15.37 2,700 49.86% 70 70.35
The Yamuna Syndicate 876 16.28 69 2.03% 52 49.46

Astal Laboratories Company Announcements - News Screener

Screen ASTALLTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-06-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-01 Announcement Under Regulation 30 (LODR) 2015- Authorization Of Kmps Under Regulation 30(5) -
2026-05-31 Announcement Under Regulation 30 (LODR) 2015- Re-Appointment Of Internal Auditor. -
2026-05-30 Results- Financial Results For March 31 2026 -
2026-05-30 Compliance- Statement Of Deviation & Variation -
2026-05-30 Results- Financial Results For March 31 2026 -
2026-05-30 Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 30Th May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations 2015. -
2026-05-27 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-26 Announcement Under Regulation 30 (LODR)- Lapse Of Convertible Warrants. -
2026-05-26 Announcement under Regulation 30 (LODR)-Allotment -
2026-05-25 Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday 30Th May 2026. -
2026-05-25 Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May 2026 -
2026-05-20 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-05-15 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-05-14 Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors -
2026-05-12 Announcement under Regulation 30 (LODR)-Allotment -
2026-05-12 Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May 2026. -
2026-05-11 Price Movement Clarification -
2026-05-11 Clarification sought from Astal Laboratories Ltd -